Dr Stephen Arneric

Guest Contributor
April 28, 2006

Dr Stephen Arneric has been appointed VP research and preclinical development at Neuromed Pharmaceuticals, a private Vancouver-based company that recently struck a major collaborative research agreement with Merck & Co Ltd (R$, March 31/06). Arneric comes to Neuromed from Pfizer Inc's Ann Arbor Laboratories where he was senior director and head for nervous systems biology. Arneric holds a PhD in pharmacology from the Univ of Iowa and received postdoctoral training at Cornell Univ Medical College. He is an adjunct professor at the Southern Illinois University School of Medicine…

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.